ERBB2 c.3149C>G ;(p.S1050*)

Variant ID: 17-37883246-C-G

NM_004448.2(ERBB2):c.3149C>G;(p.S1050*)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigms.

Oncotarget
Wheler, Jennifer J JJ; Parker, Barbara A BA; Lee, Jack J JJ; Atkins, Johnique T JT; Janku, Filip F; Tsimberidou, Apostolia M AM; Zinner, Ralph R; Subbiah, Vivek V; Fu, Siqing S; Schwab, Richard R; Moulder, Stacy S; Valero, Vicente V; Schwaederle, Maria M; Yelensky, Roman R; Miller, Vincent A VA; Stephens, M Philip J MP; Meric-Bernstam, Funda F; Kurzrock, Razelle R
Publication Date: 2014-05-15

Variant appearance in text: ERBB2: S1050*
PubMed Link: 24811890
Variant Present in the following documents:
  • oncotarget-05-2349-s001.pdf
View BVdb publication page



Temporal profiling of lapatinib-suppressed phosphorylation signals in EGFR/HER2 pathways.

Molecular & Cellular Proteomics : Mcp
Imami, Koshi K; Sugiyama, Naoyuki N; Imamura, Haruna H; Wakabayashi, Masaki M; Tomita, Masaru M; Taniguchi, Masatoshi M; Ueno, Takayuki T; Toi, Masakazu M; Ishihama, Yasushi Y
Publication Date: 2012-12

Variant appearance in text: HER2: S1050*
PubMed Link: 22964224
Variant Present in the following documents:
  • Main text
View BVdb publication page